Lipid Balm don bushewa, ƙaiƙayi, da fata mai ƙima - Taimakon Taimako na asibiti
Balm mai Saurin Yin Aiki Ga Eczema-Prone kuma Busasshiyar Fata
Lipid Balm isar da iko taimako daga ichiness, bushewa, da haushi saboda bushewa sosai ko eczema mai saurin fata- duk a ciki kamar minti 60. Mai wadatar lipids masu kama da fata, wannan ci gaban balm yana da asibiti tabbatar da gyara da kuma karfafa fata ta shingen danshi, samar da ta'aziyya na gaggawa da kuma dogon lokaci.
Me yasa Zabi Lipid Balm?
🔹 Formula Taimakon Aiki Sau Uku
Balm ɗinmu yana bayarwa anti-bushewa, maganin ƙaiƙayi, Da kuma soothing yana da fa'ida a cikin tsari mai ɗanɗano mai zurfi.
🔹 Mafi dacewa ga Eczema da Ja, Fata mai amsawa
An tsara musamman don bushewa sosai da fata mai laushi, yana taimakawa ragewa ja da rashin jin daɗi hade da yanayi kamar atopic dermatitis.
🔹 Fasahar Biomimetic don Gyaran Barrier Skin
powered by Advanced BioMimic Technology, yana bayarwa muhimman lipids, Vitamin B3, Da kuma Pro-Vitamin B5 don sake cikawa da ƙarfafa kariyar dabi'ar fatar ku.
🔹 PEA don Rage ƙaiƙayi da ja
Tsara tare da Palmitamide MEA (PEA) - abin da ke faruwa a zahiri mahadi na lipid tare da antioxidant da anti-irritant Properties - don kwantar da hankula da kuma ta'azantar da fata.
key Amfanin
-
✅ Yana aiki a cikin mintuna 60
-
✅ An tabbatar da asibiti don gyara shingen danshi
-
✅ Nan take kuma mai dorewa
-
✅ Mara kamshi, mara paraben, mara launi
-
✅ Babu sinadaran da aka samu daga dabba ko mai ma'adinai
-
✅ Amintacce don amfani akan ja, ƙaiƙayi, da fata mai saurin eczema
Yadda za a Yi amfani da
Aiwatar zuwa fata mai tsabta sau biyu a rana or kamar yadda ake bukata. Tausa a hankali a cikin fata har sai an cika shi sosai.
Sinadaran
Ruwa / Eau, Caprylic / Capric Triglyceride, Glycerin, Pentylene Glycol, Olea Europaea Man Fetur, Butyrospermum Parkii Butter, Cocos Nucifera Oil, Hydrogenated Lecithin, Palmitamide MEA, Betaine, Caprylyl Glycol, Squalane, Sarcosine, Sarcosine. Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Sodium Carbomer, Ceramide NP.
Sharhi
Babu reviews yet.